The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis
Abstract
:Simple Summary
Abstract
1. Introduction
2. Ins: Bone Senescence and Generalized Bone Loss in Aging
3. Ins: Bone Inflammaging
4. Outs: MGUS and MM Genesis According to TiDiS Theory
5. Outs: Immune Effects, Lessons from Gaucher Disease
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Salmon, S.E.; Seligmann, M. B-cell neoplasia in man. Lancet 1974, 2, 1230–1233. [Google Scholar] [CrossRef] [PubMed]
- Kyle, R.A.; Larson, D.R.; Therneau, T.M.; Dispenzieri, A.; Kumar, S.; Cerhan, J.R.; Rajkumar, S.V. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance. N. Engl. J. Med. 2018, 378, 241–249. [Google Scholar] [CrossRef] [PubMed]
- Bataille, R.; Chappard, D.; Marcelli, C.; Dessauw, P.; Sany, J.; Baldet, P.; Alexandre, C. Mechanisms of bone destruction in multiple myeloma: The importance of an unbalanced process in determining the severity of lytic bone disease. J. Clin. Oncol. 1989, 7, 1909–1914. [Google Scholar] [CrossRef] [PubMed]
- Dhodapkar, M.V.; Weinstein, R.; Tricot, G.; Jagannath, S.; Parfitt, A.M.; Manolagas, S.C.; Barlogie, B. Biologic and therapeutic determinants of bone mineral density in multiple myeloma. Leuk. Lymphoma 1998, 32, 121–127. [Google Scholar] [CrossRef]
- Drake, M.T. unveiling skeletal fragility in patients diagnosed with MGUS: No longer a condition of undetermined significance? J. Bone Miner. Res. 2014, 29, 2529–2533. [Google Scholar] [CrossRef] [Green Version]
- Lassailly, F.; Foster, K.; Lopez-Onieva, L.; Currie, E.; Bonnet, D. Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: Functional implications on hematopoietic stem cells. Blood 2013, 122, 1730–1740. [Google Scholar] [CrossRef] [Green Version]
- Itkin, T.; Gur-Cohen, S.; Spencer, J.A.; Schajnovitz, A.; Ramasamy, S.K.; Kusumbe, A.P.; Ledergor, G.; Jung, Y.; Milo, I.; Poulos, M.G.; et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature 2016, 532, 323–328. [Google Scholar] [CrossRef]
- Bonaud, A.; Lemos, J.P.; Espeli, M.; Balabanian, K. Hematopoietic Multipotent Progenitors and Plasma Cells: Neighbors or Roommates in the Mouse Bone Marrow Ecosystem? Front. Immunol. 2021, 12, 658535. [Google Scholar] [CrossRef]
- Capp, J.P.; Bataille, R. Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event. Front. Oncol. 2018, 8, 355. [Google Scholar] [CrossRef]
- Capp, J.P.; Bataille, R. Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory. Cancers 2020, 12, 2158. [Google Scholar] [CrossRef]
- Tai, Y.T.; Cho, S.F.; Anderson, K.C. Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1. Front. Immunol. 2018, 9, 1822. [Google Scholar] [CrossRef] [Green Version]
- Rosenbloom, B.E.; Cappellini, M.D.; Weinreb, N.J.; Dragosky, M.; Revel-Vilk, S.; Batista, J.L.; Sekulic, D.; Mistry, P.K. Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry. Am. J. Hematol. 2022, 97, 1337–1347. [Google Scholar] [CrossRef]
- Farr, J.N.; Khosla, S. Skeletal changes through the lifespan--from growth to senescence. Nat. Rev. Endocrinol. 2015, 11, 513–521. [Google Scholar] [CrossRef] [Green Version]
- Corrado, A.; Cici, D.; Rotondo, C.; Maruotti, N.; Cantatore, F.P. Molecular Basis of Bone Aging. Int. J. Mol. Sci. 2020, 21, 3679. [Google Scholar] [CrossRef]
- Khosla, S.; Farr, J.N.; Monroe, D.G. Cellular senescence and the skeleton: Pathophysiology and therapeutic implications. J. Clin. Invest. 2022, 132, e154888. [Google Scholar] [CrossRef]
- Pignolo, R.J.; Law, S.F.; Chandra, A. Bone Aging, Cellular Senescence, and Osteoporosis. JBMR Plus 2021, 5, e10488. [Google Scholar] [CrossRef]
- Hoffman, C.M.; Han, J.; Calvi, L.M. Impact of aging on bone, marrow and their interactions. Bone 2019, 119, 1–7. [Google Scholar] [CrossRef]
- Matteini, F.; Mulaw, M.A.; Florian, M.C. Aging of the Hematopoietic Stem Cell Niche: New Tools to Answer an Old Question. Front. Immunol. 2021, 12, 738204. [Google Scholar] [CrossRef]
- Zhang, H.; Liesveld, J.L.; Calvi, L.M.; Lipe, B.C.; Xing, L.; Becker, M.W.; Schwarz, E.M.; Yeh, S.A. The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies. Bone Res. 2023, 11, 15. [Google Scholar] [CrossRef]
- Morrison, S.J.; Scadden, D.T. The bone marrow niche for haematopoietic stem cells. Nature 2014, 505, 327–334. [Google Scholar] [CrossRef] [Green Version]
- Schepers, K.; Campbell, T.B.; Passegue, E. Normal and leukemic stem cell niches: Insights and therapeutic opportunities. Cell Stem Cell 2015, 16, 254–267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stier, S.; Ko, Y.; Forkert, R.; Lutz, C.; Neuhaus, T.; Grunewald, E.; Cheng, T.; Dombkowski, D.; Calvi, L.M.; Rittling, S.R.; et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 2005, 201, 1781–1791. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ho, Y.H.; Del Toro, R.; Rivera-Torres, J.; Rak, J.; Korn, C.; Garcia-Garcia, A.; Macias, D.; Gonzalez-Gomez, C.; Del Monte, A.; Wittner, M.; et al. Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging. Cell Stem Cell 2019, 25, 407–418.e406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ambrosi, T.H.; Scialdone, A.; Graja, A.; Gohlke, S.; Jank, A.M.; Bocian, C.; Woelk, L.; Fan, H.; Logan, D.W.; Schurmann, A.; et al. Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration. Cell Stem Cell 2017, 20, 771–784.e776. [Google Scholar] [CrossRef] [Green Version]
- Aguilar-Navarro, A.G.; Meza-Leon, B.; Gratzinger, D.; Juarez-Aguilar, F.G.; Chang, Q.; Ornatsky, O.; Tsui, H.; Esquivel-Gomez, R.; Hernandez-Ramirez, A.; Xie, S.Z.; et al. Human Aging Alters the Spatial Organization between CD34+ Hematopoietic Cells and Adipocytes in Bone Marrow. Stem Cell Rep. 2020, 15, 317–325. [Google Scholar] [CrossRef] [PubMed]
- Bataille, R.; Chappard, D.; Basle, M.F. Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: A prospective study of 87 bone biopsies. Blood 1996, 87, 4762–4769. [Google Scholar] [CrossRef] [Green Version]
- Haynes, L. Aging of the Immune System: Research Challenges to Enhance the Health Span of Older Adults. Front. Aging 2020, 1, 602108. [Google Scholar] [CrossRef]
- Di Micco, R.; Krizhanovsky, V.; Baker, D.; d’Adda di Fagagna, F. Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 2021, 22, 75–95. [Google Scholar] [CrossRef]
- Helbling, P.M.; Pineiro-Yanez, E.; Gerosa, R.; Boettcher, S.; Al-Shahrour, F.; Manz, M.G.; Nombela-Arrieta, C. Global Transcriptomic Profiling of the Bone Marrow Stromal Microenvironment during Postnatal Development, Aging, and Inflammation. Cell Rep. 2019, 29, 3313–3330.e3314. [Google Scholar] [CrossRef] [Green Version]
- Kovtonyuk, L.V.; Fritsch, K.; Feng, X.; Manz, M.G.; Takizawa, H. Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment. Front. Immunol. 2016, 7, 502. [Google Scholar] [CrossRef] [Green Version]
- Josephson, A.M.; Bradaschia-Correa, V.; Lee, S.; Leclerc, K.; Patel, K.S.; Muinos Lopez, E.; Litwa, H.P.; Neibart, S.S.; Kadiyala, M.; Wong, M.Z.; et al. Age-related inflammation triggers skeletal stem/progenitor cell dysfunction. Proc. Natl. Acad. Sci. USA 2019, 116, 6995–7004. [Google Scholar] [CrossRef] [Green Version]
- Zhu, R.; Wan, H.; Yang, H.; Song, M.; Chai, Y.; Yu, B. The Role of Senescence-Associated Secretory Phenotype in Bone Loss. Front. Cell Dev. Biol. 2022, 10, 841612. [Google Scholar] [CrossRef]
- Terkawi, M.A.; Matsumae, G.; Shimizu, T.; Takahashi, D.; Kadoya, K.; Iwasaki, N. Interplay between Inflammation and Pathological Bone Resorption: Insights into Recent Mechanisms and Pathways in Related Diseases for Future Perspectives. Int. J. Mol. Sci. 2022, 23, 1786. [Google Scholar] [CrossRef]
- Metzger, C.E.; Narayanan, S.A. The Role of Osteocytes in Inflammatory Bone Loss. Front. Endocrinol. 2019, 10, 285. [Google Scholar] [CrossRef]
- Marriott, I.; Gray, D.L.; Tranguch, S.L.; Fowler, V.G., Jr.; Stryjewski, M.; Scott Levin, L.; Hudson, M.C.; Bost, K.L. Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Am. J. Pathol. 2004, 164, 1399–1406. [Google Scholar] [CrossRef] [Green Version]
- Bussard, K.M.; Venzon, D.J.; Mastro, A.M. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. J. Cell. Biochem. 2010, 111, 1138–1148. [Google Scholar] [CrossRef] [Green Version]
- Wang, Y.; Li, S.; Zhao, L.; Cheng, P.; Liu, J.; Guo, F.; Xiao, J.; Zhu, W.; Chen, A. Aging Relevant Metabolite Itaconate Inhibits Inflammatory Bone Loss. Front. Endocrinol. 2022, 13, 885879. [Google Scholar] [CrossRef]
- Giuliani, N.; Colla, S.; Sala, R.; Moroni, M.; Lazzaretti, M.; La Monica, S.; Bonomini, S.; Hojden, M.; Sammarelli, G.; Barille, S.; et al. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: A potential role in multiple myeloma bone disease. Blood 2002, 100, 4615–4621. [Google Scholar] [CrossRef] [Green Version]
- Bosseboeuf, A.; Allain-Maillet, S.; Mennesson, N.; Tallet, A.; Rossi, C.; Garderet, L.; Caillot, D.; Moreau, P.; Piver, E.; Girodon, F.; et al. Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins. Front. Immunol. 2017, 8, 1347. [Google Scholar] [CrossRef] [Green Version]
- Capp, J.P.; Bataille, R. A bone paradigm challenging the standard model of myeloma oncogenesis. Crit. Rev. Oncol. Hematol. 2022, 172, 103640. [Google Scholar] [CrossRef]
- Lindquist, R.L.; Niesner, R.A.; Hauser, A.E. In the Right Place, at the Right Time: Spatiotemporal Conditions Determining Plasma Cell Survival and Function. Front. Immunol. 2019, 10, 788. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Visnjic, D.; Kalajzic, Z.; Rowe, D.W.; Katavic, V.; Lorenzo, J.; Aguila, H.L. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004, 103, 3258–3264. [Google Scholar] [CrossRef] [PubMed]
- Zehentmeier, S.; Pereira, J.P. Cell circuits and niches controlling B cell development. Immunol. Rev. 2019, 289, 142–157. [Google Scholar] [CrossRef] [PubMed]
- Chen, Z.; Orlowski, R.Z.; Wang, M.; Kwak, L.; McCarty, N. Osteoblastic niche supports the growth of quiescent multiple myeloma cells. Blood 2014, 123, 2204–2208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lawson, M.A.; McDonald, M.M.; Kovacic, N.; Hua Khoo, W.; Terry, R.L.; Down, J.; Kaplan, W.; Paton-Hough, J.; Fellows, C.; Pettitt, J.A.; et al. Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nat. Commun. 2015, 6, 8983. [Google Scholar] [CrossRef] [Green Version]
- Madel, M.B.; Ibanez, L.; Wakkach, A.; de Vries, T.J.; Teti, A.; Apparailly, F.; Blin-Wakkach, C. Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions. Front. Immunol. 2019, 10, 1408. [Google Scholar] [CrossRef]
- Garcia-Ortiz, A.; Rodriguez-Garcia, Y.; Encinas, J.; Maroto-Martin, E.; Castellano, E.; Teixido, J.; Martinez-Lopez, J. The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression. Cancers 2021, 13, 217. [Google Scholar] [CrossRef]
- Schinke, C.; Poos, A.M.; Bauer, M.; John, L.; Johnson, S.; Deshpande, S.; Carrillo, L.; Alapat, D.; Rasche, L.; Thanendrarajan, S.; et al. Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level. Blood Adv. 2022, 6, 5873–5883. [Google Scholar] [CrossRef]
- Adamik, J.; Galson, D.L.; Roodman, G.D. Osteoblast suppression in multiple myeloma bone disease. J. Bone Oncol. 2018, 13, 62–70. [Google Scholar] [CrossRef]
- Harb, J.; Mennesson, N.; Lepetit, C.; Fourny, M.; Louvois, M.; Bosseboeuf, A.; Allain-Maillet, S.; Decaux, O.; Moreau, C.; Tallet, A.; et al. Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens. Cells 2021, 10, 438. [Google Scholar] [CrossRef]
- Zojer, N.; Ludwig, H.; Fiegl, M.; Stevenson, F.K.; Sahota, S.S. Patterns of somatic mutations in VH genes reveal pathways of clonal transformation from MGUS to multiple myeloma. Blood 2003, 101, 4137–4139. [Google Scholar] [CrossRef] [Green Version]
- Feuerer, M.; Beckhove, P.; Garbi, N.; Mahnke, Y.; Limmer, A.; Hommel, M.; Hammerling, G.J.; Kyewski, B.; Hamann, A.; Umansky, V.; et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 2003, 9, 1151–1157. [Google Scholar] [CrossRef]
- Mucci, J.M.; Rozenfeld, P. Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System. J. Immunol. Res. 2015, 2015, 192761. [Google Scholar] [CrossRef] [Green Version]
- Nair, S.; Branagan, A.R.; Liu, J.; Boddupalli, C.S.; Mistry, P.K.; Dhodapkar, M.V. Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma. N. Engl. J. Med. 2016, 374, 555–561. [Google Scholar] [CrossRef]
- Nair, S.; Sng, J.; Boddupalli, C.S.; Seckinger, A.; Chesi, M.; Fulciniti, M.; Zhang, L.; Rauniyar, N.; Lopez, M.; Neparidze, N.; et al. Antigen-mediated regulation in monoclonal gammopathies and myeloma. JCI Insight 2018, 3, e98259. [Google Scholar] [CrossRef] [Green Version]
- Nair, S.; Bar, N.; Xu, M.L.; Dhodapkar, M.; Mistry, P.K. Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy. Mol. Genet. Metab. 2020, 129, 286–291. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Capp, J.-P.; Bataille, R. The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis. Biology 2023, 12, 990. https://doi.org/10.3390/biology12070990
Capp J-P, Bataille R. The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis. Biology. 2023; 12(7):990. https://doi.org/10.3390/biology12070990
Chicago/Turabian StyleCapp, Jean-Pascal, and Régis Bataille. 2023. "The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis" Biology 12, no. 7: 990. https://doi.org/10.3390/biology12070990
APA StyleCapp, J. -P., & Bataille, R. (2023). The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis. Biology, 12(7), 990. https://doi.org/10.3390/biology12070990